Back to News
Market Impact: 0.2
Immutep Limited Receives A$2.16 million French R&D Tax Incentive
Source: Nasdaq
Healthcare & BiotechTax & TariffsCompany Fundamentals
Immutep Limited received €1.36 million (approximately A$2.16 million) from the French Government through its Crédit d’Impôt Recherche research tax incentive program. The payment relates to eligible R&D activities; the article text is truncated before specifying the activity period.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
IMMP0.35
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- PC chip plunge wipes out a quarter of Intel’s value
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up